CD4 and cancer: Finally, ID8-p53−/− and STOSE were significantly infiltrated by CD11b+CD11c+ cells, which includes conventional DC2s (cDC2) that are mainly recognized by the induction of CD4+ T-cell immunity in cancer (ref. 31; Fig. 3I).